Alpha 2.0
Login Register
» Articles » PMID: 22102440

Prognosis and Staging of Non-alcoholic Fatty Liver Disease

Overview
Journal BMJ
Specialty General Medicine
Date 2011 Nov 22
PMID 22102440
Citations 4
Authors
Peter Jepsen
Henning Gronbaek
Affiliations
Soon will be listed here.
Citing Articles

Plasma Fatty Acid Composition Is Associated with Histological Findings of Nonalcoholic Steatohepatitis.

Miyake T, Furukawa S, Matsuura B, Yoshida O, Miyazaki M, Shiomi A Biomedicines. 2022; 10(10).

PMID: 36289802 PMC: 9599601. DOI: 10.3390/biomedicines10102540.

Aromatase Inhibitors and Newly Developed Nonalcoholic Fatty Liver Disease in Postmenopausal Patients with Early Breast Cancer: A Propensity Score-Matched Cohort Study.

Lee J, Yu J, Anh S, Lee H, Jeong J, Lee K Oncologist. 2019; 24(8):e653-e661.

PMID: 30679317 PMC: 6693701. DOI: 10.1634/theoncologist.2018-0370.

Nonalcoholic fatty liver disease (NAFLD) in the Veterans Administration population: development and validation of an algorithm for NAFLD using automated data.

Husain N, Blais P, Kramer J, Kowalkowski M, Richardson P, El-Serag H Aliment Pharmacol Ther. 2014; 40(8):949-54.

PMID: 25155259 PMC: 5331854. DOI: 10.1111/apt.12923.

Serum oxidative stress markers and lipidomic profile to detect NASH patients responsive to an antioxidant treatment: a pilot study.

Stiuso P, Scognamiglio I, Murolo M, Ferranti P, De Simone C, Rizzo M Oxid Med Cell Longev. 2014; 2014:169216.

PMID: 24987492 PMC: 4060161. DOI: 10.1155/2014/169216.